3 ms·
Also, Merck itself still doesn't recommend it, citing: "No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, an
by browningstreet 5y ago
Also, Merck itself still doesn't recommend it, citing:
"No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;
A concerning lack of safety data in the majority of studies."
https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/ https://www.merck.com/news/merck-statement-on-ivermectin-use...
Cynically, you could say they should be motivated to support this trend, as it would be more $ for them. But that hasn't happened yet.
- _-david-_ 5y agoMerck is going to receive money ($1.2 billion) from the government for an alternative treatment. There are generics of Ivermectin so even if it does work Merck would want to push their new drug instead of Ivermectin. If this was not related to covid nobody here would be trusting Merck due to this conflict of interest. https://www.merck.com/news/merck-announces-supply-agreement-with-u-s-government-for-molnupiravir-an-investigational-oral-antiviral-candidate-for-treatment-of-mild-to-moderate-covid-19/ https://www.merck.com/news/merck-announces-supply-agreement-...
- deleted 5y ago[deleted]